136 related articles for article (PubMed ID: 23288633)
41. Pharmacogenomic-Guided Therapy in Colorectal Cancer.
Diasio RB; Innocenti F; Offer SM
Clin Pharmacol Ther; 2021 Sep; 110(3):616-625. PubMed ID: 34114648
[TBL] [Abstract][Full Text] [Related]
42. Targeting IL-8 in colorectal cancer.
Ning Y; Lenz HJ
Expert Opin Ther Targets; 2012 May; 16(5):491-7. PubMed ID: 22494524
[TBL] [Abstract][Full Text] [Related]
43. A review of the evolution of systemic chemotherapy in the management of colorectal cancer.
Gustavsson B; Carlsson G; Machover D; Petrelli N; Roth A; Schmoll HJ; Tveit KM; Gibson F
Clin Colorectal Cancer; 2015 Mar; 14(1):1-10. PubMed ID: 25579803
[TBL] [Abstract][Full Text] [Related]
44. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents.
Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
Bioorg Med Chem; 2012 Aug; 20(15):4848-55. PubMed ID: 22750007
[TBL] [Abstract][Full Text] [Related]
45. [Cetuximab (Erbitux)].
Shimoyama T
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1203-12. PubMed ID: 19620819
[TBL] [Abstract][Full Text] [Related]
46. Patrinia scabiosaefolia induces mitochondrial-dependent apoptosis in a mouse model of colorectal cancer.
Liu L; Shen A; Chen Y; Wei L; Lin J; Sferra TJ; Hong Z; Peng J
Oncol Rep; 2013 Aug; 30(2):897-903. PubMed ID: 23754194
[TBL] [Abstract][Full Text] [Related]
47. The molecular rationale of Src inhibition in colorectal carcinomas.
Gargalionis AN; Karamouzis MV; Papavassiliou AG
Int J Cancer; 2014 May; 134(9):2019-29. PubMed ID: 23733480
[TBL] [Abstract][Full Text] [Related]
48. Basics to advances in nanotherapy of colorectal cancer.
Tiwari A; Saraf S; Jain A; Panda PK; Verma A; Jain SK
Drug Deliv Transl Res; 2020 Apr; 10(2):319-338. PubMed ID: 31701486
[TBL] [Abstract][Full Text] [Related]
49. Natural and synthetic retinoids in preclinical colorectal cancer models.
Abdel-Samad R; Aouad P; Darwiche N
Anticancer Drugs; 2019 Aug; 30(7):e0802. PubMed ID: 31021825
[TBL] [Abstract][Full Text] [Related]
50. Phytochemicals - A Novel and Prominent Source of Anti-cancer Drugs Against Colorectal Cancer.
Mahadevappa R; Kwok HF
Comb Chem High Throughput Screen; 2017; 20(5):376-394. PubMed ID: 28078982
[TBL] [Abstract][Full Text] [Related]
51. Enhancing oncogenic signaling to kill cancer cells.
Noeparast M; Timofeev O; Pichler M
Trends Pharmacol Sci; 2024 Jun; 45(6):475-477. PubMed ID: 38734500
[TBL] [Abstract][Full Text] [Related]
52. Colorectal cancer drug target prediction using ontology-based inference and network analysis.
Tao C; Sun J; Zheng WJ; Chen J; Xu H
Database (Oxford); 2015; 2015():. PubMed ID: 25818893
[TBL] [Abstract][Full Text] [Related]
53. Evolution of the management of colorectal cancer using integrative medicine.
Li ST; Chi P
Chin J Integr Med; 2011 Jan; 17(1):73-9. PubMed ID: 21258900
[TBL] [Abstract][Full Text] [Related]
54. Melatonin as a potential inhibitor of colorectal cancer: Molecular mechanisms.
Shafabakhsh R; Reiter RJ; Davoodabadi A; Asemi Z
J Cell Biochem; 2019 Aug; 120(8):12216-12223. PubMed ID: 31087705
[TBL] [Abstract][Full Text] [Related]
55. Peptides for diagnosis and treatment of colorectal cancer.
Shapira S; Fokra A; Arber N; Kraus S
Curr Med Chem; 2014; 21(21):2410-6. PubMed ID: 24524764
[TBL] [Abstract][Full Text] [Related]
56. Antimicrobial peptides against colorectal cancer-a focused review.
Chauhan S; Dhawan DK; Saini A; Preet S
Pharmacol Res; 2021 May; 167():105529. PubMed ID: 33675962
[TBL] [Abstract][Full Text] [Related]
57. [Contributions of molecular biology to the management of colorectal cancer].
Grancher A; Cuissy S; Sefrioui D; Di Fiore F
Rev Prat; 2024 Apr; 74(4):355-358. PubMed ID: 38814021
[TBL] [Abstract][Full Text] [Related]
58. Colorectal cancer and molecular targeted agents: progress--with caveats.
Tenner LL; O'Neil BH
Oncology (Williston Park); 2014 Feb; 28(2):125, 128. PubMed ID: 24701699
[No Abstract] [Full Text] [Related]
59. The utility of molecular testing in colorectal cancer: the promise needs progress.
Azad NS; Diaz LA
Oncology (Williston Park); 2014 Feb; 28(2):118-9, 125. PubMed ID: 24701698
[No Abstract] [Full Text] [Related]
60. Antineoplastic agents.
Carlson PA
Crit Care Nurs Q; 1996 Feb; 18(4):1-15. PubMed ID: 8689448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
